Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells  Wen-Jane Lee, PhD, Hsiu-Chung.

Slides:



Advertisements
Similar presentations
Fig. 1. Impact of AA on ROS generation by human spermatozoa
Advertisements

Volume 65, Issue 5, Pages (May 2004)
Β-Glucan attenuates inflammatory responses in oxidized LDL-induced THP-1 cells via the p38 MAPK pathway  S. Wang, H. Zhou, T. Feng, R. Wu, X. Sun, N.
Differential effects of GLP-1 receptor agonist on foam cell formation in monocytes between non-obese and obese subjects  Masashi Tanaka, Yoshiyuki Matsuo,
Chrysin restores PDGF-induced inhibition on protein tyrosine phosphatase and reduces PDGF signaling in cultured VSMCs  Huey-Ming Lo, Min-Wen Wu, Shiow-Lin.
Oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX- 1) in cultured bovine articular chondrocytes increases production.
Yan Huang, Lanxi Song, Shan Wu, Fan Fan, Maria F Lopes-Virella 
From: miR-124 Regulates Amadori-Glycated Albumin-Induced Retinal Microglial Activation and Inflammation by Targeting Rac1 Invest. Ophthalmol. Vis. Sci..
Arterioscler Thromb Vasc Biol
Bone Morphogenic Protein 4 Produced in Endothelial Cells by Oscillatory Shear Stress Induces Monocyte Adhesion by Stimulating Reactive Oxygen Species Production.
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Volume 62, Issue 6, Pages (December 2002)
Crude extracts of Solanum lyratum protect endothelial cells against oxidized low-density lipoprotein-induced injury by direct antioxidant action  Wei-Wen.
Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure  Oscar.
Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like.
Sandhya K. Balaram, MD, Devendra K. Agrawal, PhD, R
Volume 9, Issue 5, Pages (November 1998)
Adult Aortic Valve Interstitial Cells Have Greater Responses to Toll-Like Receptor 4 Stimulation  Xin-Sheng Deng, MD, Xianzhong Meng, MD, PhD, QingChun.
Role of reactive oxygen species in inhibition of endothelial cell migration by oxidized low-density lipoprotein  John A. van Aalst, MD, Dong-Mei Zhang,
Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells  Wen-Jane Lee, PhD, Hsiu-Chung.
Crude extracts of Solanum lyratum protect endothelial cells against oxidized low-density lipoprotein-induced injury by direct antioxidant action  Wei-Wen.
M. -H. Moon, J. -K. Jeong, Y. -J. Lee, J. -W. Seol, C. J. Jackson, S
Hyperphosphatemia induces protective autophagy in endothelial cells through the inhibition of Akt/mTOR signaling  Yu-Juei Hsu, MD, PhD, Shih-Che Hsu,
Lipopolysaccharide Activates Caspase-1 (Interleukin-1–Converting Enzyme) in Cultured Monocytic and Endothelial Cells by Ralf R. Schumann, Claus Belka,
Bertrand Poussier, MD, Alfredo C
Signal transduction pathways triggered by the FcϵRIIb receptor (CD23) in human monocytes lead to nuclear factor-κB activation  Rosa M. Ten, MD, PhDa,
Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1 by Andreas H. Wagner, Matthias Gebauer, Beatrix.
Repetitive progressive thermal preconditioning hinders thrombosis by reinforcing phosphatidylinositol 3-kinase/Akt-dependent heat-shock protein/endothelial.
Hyperphosphatemia induces protective autophagy in endothelial cells through the inhibition of Akt/mTOR signaling  Yu-Juei Hsu, MD, PhD, Shih-Che Hsu,
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Aspirin prevents resistin-induced endothelial dysfunction by modulating AMPK, ROS, and Akt/eNOS signaling  Hsiu-Chung Ou, PhD, Wen-Jane Lee, PhD, Ching-Mei.
Volume 96, Issue 10, Pages (May 2009)
Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated.
Larry W. Kraiss, MDa,b,c, Neal M. Alto, BSa,c, Dan A
Sandhya K. Balaram, MD, Devendra K. Agrawal, PhD, R
Volume 68, Issue 6, Pages (December 2005)
Volume 124, Issue 5, Pages (May 2003)
Volume 15, Issue 3, Pages (March 2012)
Translocation of protein kinase C isoforms is involved in propofol-induced endothelial nitric oxide synthase activation  L. Wang, B. Wu, Y. Sun, T. Xu,
Daniel J. Wong, MD, Daniel Y. Lu, MD, Clinton D
Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-α  John T. Schroeder, PhD,
Sphingosine-1-phosphate–induced oxygen free radical generation in smooth muscle cell migration requires Gα12/13 protein-mediated phospholipase C activation 
Ambient pressure upregulates nitric oxide synthase in a phosphorylated-extracellular regulated kinase– and protein kinase C–dependent manner  Angela G.
Tumor necrosis factor α up-regulates endometrial milk fat globule–epidermal growth factor 8 protein production via nuclear factor κB activation, resulting.
Simvastatin Protects Human Melanocytes from H2O2-Induced Oxidative Stress by Activating Nrf2  Yuqian Chang, Shuli Li, Weinan Guo, Yuqi Yang, Weigang Zhang,
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX- 1) in cultured bovine articular chondrocytes increases production.
Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells  Mimi Sohn, Yan Tan, Richard L. Klein, Ayad.
Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation: Modulation of Molecular Pathways of Radioresistance and Tumor Suppression  Toran Sanli,
Glucocorticoids inhibit IL-4 and mitogen-induced IL-4Rα chain expression by different posttranscriptional mechanisms  Lourdes Mozo, PhDa, Abel Gayo, BSa,
Volume 63, Issue 2, Pages (February 2003)
Volume 133, Issue 5, Pages (November 2007)
Endothelial expression of intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 is suppressed by postbypass plasma containing increased.
Sphingosine-1-phosphate–induced smooth muscle cell migration involves the mammalian target of rapamycin  William J. Tanski, MD, Suzanne M. Nicholl, PhD,
Sang-Wahn Koo, Katherine A. Casper, Kristen B. Otto, Amy K
Estrogen receptor β agonist diarylpropionitrile inhibits lipopolysaccharide-induced regulated on activation normal T cell expressed and secreted (RANTES)
Secretory Phospholipase A2 Inhibition Attenuates Intercellular Adhesion Molecule-1 Expression in Human Esophageal Adenocarcinoma Cells  Miral R. Sadaria,
P38 Mitogen-activated Protein Kinase and Extracellular Signal-regulated Kinases Play Distinct Roles in the Activation of Dendritic Cells by Two Representative.
The effects of ginsenoside Rb1 on endothelial damage and ghrelin expression induced by hyperhomocysteine  Zhiwei Xu, PhD, Taohua Lan, MD, Weikang Wu,
Ketoconazole Suppresses Prostaglandin E2-Induced Cyclooxygenase-2 Expression in Human Epidermoid Carcinoma A-431 Cells  Naoko Kanda, Dr., Shinichi Watanabe 
All-Trans-Retinoic Acid Induces Interleukin-8 via the Nuclear Factor-κB and p38 Mitogen-Activated Protein Kinase Pathways in Normal Human Keratinocytes 
Volume 138, Issue 7, Pages e1 (June 2010)
P38 Mitogen-Activated Protein Kinase Mediates Dual Role of Ultraviolet B Radiation in Induction of Maturation and Apoptosis of Monocyte-Derived Dendritic.
Volume 15, Issue 3, Pages (March 2012)
Inducible Nitric Oxide Synthase Up-Regulates Notch-1 in Mouse Cholangiocytes: Implications for Carcinogenesis  Norihisa Ishimura, Steven F. Bronk, Gregory.
Activation and Translocation of p38 Mitogen-Activated Protein Kinase After Stimulation of Monocytes With Contact Sensitizers  Pia Brand, Sibylle Plochmann,
SIRT1, a Class III Histone Deacetylase, Regulates LPS-Induced Inflammation in Human Keratinocytes and Mediates the Anti-Inflammatory Effects of Hinokitiol 
Volume 55, Issue 6, Pages (June 1999)
Coupling of Contact Sensitizers to Thiol Groups is a Key Event for the Activation of Monocytes and Monocyte-Derived Dendritic Cells  Detlef Becker, Elke.
Modulation of monocyte adherence to endothelial cells by endothelin-1 involvement of Src (p60src) and JAK1-like kinases  Lindsey J. Chisholm, MB, BS,
Presentation transcript:

Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells  Wen-Jane Lee, PhD, Hsiu-Chung Ou, PhD, Wen-Cheng Hsu, MD, Min-Min Chou, MD, Jenn-Jhy Tseng, MD, PhD, Shih-Lan Hsu, PhD, Kun-Ling Tsai, MS, Wayne Huey-Herng Sheu, MD, PhD  Journal of Vascular Surgery  Volume 52, Issue 5, Pages 1290-1300 (November 2010) DOI: 10.1016/j.jvs.2010.04.085 Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 1 Inhibitory effect of ellagic acid on oxidized low-density lipoprotein (oxLDL)-induced endothelial LOX-1 protein expression. Human umbilical vein endothelial cells (HUVECs) were pretreated with ellagic acid (5-20 μM) or DPI (5 μM) for 2 hours followed by exposure to oxLDL (150 μg/mL) for a further 24-hour period. At the end of the incubation period, cells were lysed and proteins were analyzed by Western blot. Protein levels of LOX-1 were normalized to the level of β-actin. Data illustrated on the graph bars represent the mean ± SEM of three different experiments. *P < .05 compared with oxLDL-stimulated HUVECs. Journal of Vascular Surgery 2010 52, 1290-1300DOI: (10.1016/j.jvs.2010.04.085) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 2 Inhibitory effects of ellagic acid on oxidized low-density lipoprotein (oxLDL)-induced reactive oxygen species (ROS) production in human umbilical vein endothelial cells (HUVECs). After pre-incubation for 2 hours with the indicated concentrations of ellagic acid (5-20 μM), cells were treated with 150 μg/mL oxLDL for 2 hours followed by a 1-hour incubation with superoxide-sensitive fluorescent probe DHE (10 μM). (A) Fluorescence images show the ROS level in control cells (left) and HUVECs stimulated with oxLDL alone (middle) and in the presence of 10 μM ellagic acid (right). (B) Fluorescence intensity of cells was measured with a fluorescence microplate reader. Fluorescence distribution of DHE oxidation is expressed as a percentage of increased intensity. (C, D) Representative Western blots of Cu, Zn-SOD (SOD-1), and Mn-SOD (SOD-2) protein levels in HUVECs pretreated with ellagic acid for 2 hours followed by stimulation with 150 μg/mL oxLDL for 24 hours. Data are expressed as the mean ± SEM of three independent analyses. *P < .05 compared with oxLDL-stimulated HUVECs. Journal of Vascular Surgery 2010 52, 1290-1300DOI: (10.1016/j.jvs.2010.04.085) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 3 Ellagic acid attenuated the level of NADPH oxidase membrane assembly. Human umbilical vein endothelial cells (HUVECs) were pretreated for 2 hours with the indicated concentrations of ellagic acid followed by stimulation with oxidized low-density lipoprotein (oxLDL) (150 μg/mL) for 1 hour (A-C) or 24 hours (D-F). Preparation of membrane and cytosolic proteins is described in the Material and Methods section. The levels of cytosolic protein and membrane protein were normalized to the levels of β-actin and flotillin-1, respectively. Representative Western blots and summary data showed that ellagic acid protected against oxLDL-induced p47phox and Rac-1 translocation to the plasma membrane, and gp91 as well as p22phox expression. The values represent means ± SEM from three separate experiments. *P < .05 vs oxLDL treatment. Journal of Vascular Surgery 2010 52, 1290-1300DOI: (10.1016/j.jvs.2010.04.085) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 4 Ellagic acid ameliorated the oxidized low-density lipoprotein (oxLDL)-down-regulated eNOS and up-regulated iNOS protein expression (A-C), oxLDL-enhanced NO release (D), and nitration of tyrosine residues (E, F). In addition, ellagic acid attenuated the oxLDL-enhanced secretion of ET-1 (G). Human umbilical vein endothelial cells (HUVECs) were pretreated for 2 hours with the indicated concentrations of ellagic acid followed by stimulation with oxLDL (150 μg/mL) for 24 hours. At the end of the incubation period, level of eNOS, iNOS, and nitrotyrosine protein (normalized to the levels of β-actin) were determined by immunoblotting; content of NO was assayed using Gries reagent; ET-1 secretion was measured by ELISA. The values represent means ± SEM from three separate experiments. *P < .05 vs oxLDL treatment. Journal of Vascular Surgery 2010 52, 1290-1300DOI: (10.1016/j.jvs.2010.04.085) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 5 Ellagic acid inhibits oxidized low-density lipoprotein (oxLDL)-induced p38MAPK protein phosphorylation (p-p38MAPK). Human umbilical vein endothelial cells (HUVECs) were pretreated for 2 hours with the indicated concentrations of ellagic acid followed by stimulation with oxLDL (150 μg/mL) for 1 hour. Expression of p38MAPK was analyzed by Western blotting and quantified by densitometry. Treatment with 10 μM SB203580, a specific inhibitor of p38 MAPK, suppressed the oxLDL-induced phosphorylation of the p38MAPK protein. The values represent means ± SEM from three separate experiments. *P < .05 vs oxLDL treatment. Journal of Vascular Surgery 2010 52, 1290-1300DOI: (10.1016/j.jvs.2010.04.085) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 6 Effects of ellagic acid on oxidized low-density lipoprotein (oxLDL)-induced NF-κB activation. Human umbilical vein endothelial cells (HUVECs) were pretreated for 2 hours with the indicated concentrations of ellagic acid followed by stimulation with oxLDL (150 μg/mL) for 1 hour. Preparation of cytosolic and nuclear proteins is described in the Material and Methods section. The expression levels of the indicated proteins were analyzed by Western blotting and quantified by densitometry (A). The levels of cytosolic protein and nuclear protein were normalized to the levels of β-actin and proliferating cell nuclear antigen, respectively (B, C). The values represent means ± SEM from three separate experiments. *P < .05 vs oxLDL treatment. Journal of Vascular Surgery 2010 52, 1290-1300DOI: (10.1016/j.jvs.2010.04.085) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 7 Effects of ellagic acid on oxidized low-density lipoprotein (oxLDL)-induced release of inflammatory cytokines, expression of adhesion molecules, and adhesiveness of THP-1 monocytic cells to human umbilical vein endothelial cells (HUVECs). Cells were incubated with indicated concentrations of ellagic acid for 2 hours and then incubated with ox-LDL for an additional 24 hours. ELISA measurements showing IL-6 (A) and IL-8 (B) protein levels in HUVECs treated with oxLDL in the absence or presence of indicated concentrations of ellagic acid. (C) HUVECs were incubated with oxLDL (150 μg/mL) in the absence (light gray) or presence (dark gray) of 20 μM ellagic acid for 24 hours. The histograms of cell surface expression of ICAM-1, VCAM-1, and E-selectin were generated by flow cytometry. (D) Representative fields of monocytes adhering to HUVECs with representative treatments as indicated. (E) Dose-dependent effect of ellagic acid (5-20 μM) on oxLDL (150 μg/mL)-induced adhesiveness of THP-1 to HUVECs was measured as described in the Materials and Methods section. The values represent mean ± SEM of three independent analyses. *P < .05 vs. oxLDL treatment. Journal of Vascular Surgery 2010 52, 1290-1300DOI: (10.1016/j.jvs.2010.04.085) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 8 Schematic diagram showing cytoprotective signaling of ellagic acid in oxidized low-density lipoprotein (oxLDL)-induced endothelial dysfunction. As depicted, ellagic acid inhibits the LOX-1-mediated signaling cascades initiated by oxLDL-generated reactive oxygen species (ROS). The → indicates activation or induction, and ⊣ indicates inhibition or blockade. Journal of Vascular Surgery 2010 52, 1290-1300DOI: (10.1016/j.jvs.2010.04.085) Copyright © 2010 Society for Vascular Surgery Terms and Conditions